TTD | Drug: D01HGT

Drug General Information
Drug ID	D01HGT
Former ID	DCL001142
Drug Name	Anti-CD22
Drug Type	Antibody
Indication	Hematologic malignancies [ICD9: 200-209; ICD10:C81-C86]		Phase 1	[551667]
Company	Seattle Genetics; Genentech
Target and Pathway
Target(s)	B-cell receptor CD22	Target Info		[551667]
KEGG Pathway	Cell adhesion molecules (CAMs)
	Hematopoietic cell lineage
	B cell receptor signaling pathway
PANTHER Pathway	B cell activation
Pathway Interaction Database	BCR signaling pathway
Reactome	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
Reactome	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
WikiPathways	B Cell Receptor Signaling Pathway
References
Ref 551667	2011 Pipeline of Seattle Genetics.
Ref 551667	2011 Pipeline of Seattle Genetics.

Drug Information